• Skip to main content
  • Skip to main content
Choose which site to search.
University of Arkansas for Medical Sciences Logo University of Arkansas for Medical Sciences
College of Medicine: Department of Pharmacology and Toxicology
  • UAMS Health
  • Jobs
  • Giving
  • About Us
    • Alumni
    • Contact Us
  • Faculty/Staff
    • Primary Faculty
    • Secondary Faculty
    • Emeritus Faculty
    • Administrative Staff
  • Postdoctoral Fellows
  • Students
    • Graduate Program in Interdisciplinary Sciences (GPIBS)
      • Pharmacology, Toxicology and Experimental Therapeutics (PTET)
      • SPaT
        • SPaT Faculty
        • SPaT Trainees
        • SPaT Trainee Publications
        • SPaT Annual Symposium
        • Program Outcomes
    • Meet Our Students
    • Graduate School Application
    • Journal Club
    • Summer Undergraduate Research Program (SURF)
    • Graduates
  • Research Areas
  • Seminars
  • News
  • Fouda Lab News
  1. University of Arkansas for Medical Sciences
  2. College of Medicine
  3. Department of Pharmacology and Toxicology
  4. Faculty/Staff
  5. Primary Faculty
  6. Zufeng Ding, Ph.D.

Zufeng Ding, Ph.D.

Zufeng Ding

Assistant Professor

Office: Biomed 1, B306F
Phone: 501-686-7936
Email: ZDing@uams.edu

Education and Training

  • Assistant Professor, University of Arkansas for Medical Sciences 
    2016-
  • Instructor, University of Arkansas for Medical Sciences
    2014-2015
  • Post-doctoral training, University of Arkansas for Medical Sciences
    2011-2014
  • Ph.D. in Biomedical Engineering, Beihang University, Beijing, China
    2005-2010
  • B.S. in Bioengineering, Henan University, Kaifeng, Henan, China
    2001-2005

Research Interests

Our primary research interests focus on hemodynamic shear stress, inflammation (e.g. NLRP3 inflammasome and TLR4), mitochondrial DNA damage, programmed cell death (e.g., apoptosis, autophagy, and pyroptosis) and efferocytosis, and their roles in the development of cardiovascular diseases, such as atherosclerosis, myocardial infarction, and aging. Our studies also focus on stem cell therapy, such as use of mesenchymal stem cells and induced pluripotent stem cells, to treat cardiovascular diseases. One of  our current studies is trying to computationally integrate state-of-the-art single-cell RNA sequencing (scRNA-seq) with bulk RNA-sequencing and mass spectrometry-driven proteomics to generate a multi-omics whole organ resource of molecular/cellular alterations.

Research Support

Ongoing

  • R01  NHLBI R01HL162958      Ding (PI)                             
    Impact of hemodynamics on efferocytosis in endothelial cells  04/01/2022 – 03/31/2027   
  • R21   NIA R21AG075548         Ding (PI)                               
    Mechanisms of PCSK9 in endothelial aging  01/01/2022-11/30/2023
  • UAMS Bronson Foundation   Ding (PI)                               
    Mechanisms of endothelial efferocytosis in vascular aging 01/01/2022-12/31/2022                                                                                                                                          

Recent and Selected Publications                                                                         

  1. Stolarz AJ, Mu S, Zhang H, Fouda AY, Rusch NJ, Ding Z*. Endothelial Cells – Macrophage-Like Gatekeepers? Front Immunol. 2022;13:902945. 
  2. Li X, Brickell A, Wang X, Zhou S, Ding Z*. NADPH oxidase promotes PCSK9 secretion in macrophages. J Mol Cell Cardiol. 2021, 153:42-43. 
  3. Wang X, Li X, Liu S, Brickell A, Zhang J, Wu Z, Zhou S, Ding Z*. PCSK9 regulates pyroptosis via mtDNA damage in chronic myocardial ischemia. Basic Res Cardiol. 2020, 115:66.  
  4. Liu S, Deng X, Zhang P, Wang X, Fan Y, Zhou S, Mu S, Mehta JL, Ding Z*. Blood flow patterns regulate PCSK9 secretion via MyD88 mediated proinflammatory cytokines. Cardiovasc Res. 2020; 116:1721-32.  
  5. Ding Z*, Pothineni NVK, Goel A, Lüscher TF, Mehta JL. PCSK9 and inflammation: Role of shear stress, pro-inflammatory cytokines and LOX-1. Cardiovasc Res. 2020;116:908-915. 
  6. Ding Z*, Wang X, Liu S, Zhou S, Kore R, Mu S, Deng X, Fan Y, Mehta JL. NLRP3 inflammasome via IL-1β regulates PCSK9 secretion. Theranostics. 2020, 10:7100-7110. 
  7. Ding Z*, Wang X, Liu S, Shahanawaz J, Theus S, Fan Y, Deng X, Zhou S, Mehta JL. PCSK9 expression in the ischemic heart and its relationship to infarct size, cardiac function and development of autophagy. Cardiovasc Res. 2018;114:1738-1751.
  8. Ding Z*, Liu S, Wang X, Theus S, Deng X, Fan Y, Zhou S, Mehta JL. PCSK9 regulates expression of scavenger receptors and ox-LDL uptake in macrophages. Cardiovasc Res. 2018;114:1145-1153. 
  9. Ding Z, Liu S, Wang X, Mathur P, Dai Y, Theus S, Deng X, Fan Y, Mehta JL. Cross-talk between PCSK9 and damaged mtDNA in vascular smooth muscle cells: role in apoptosis. Antioxid Redox Signal. 2016, 25:997-1008.
  10. Ding Z, Liu S, Wang X, Dai Y, Deng X, Fan Y, Sun C, Wang Y, Mehta JL. Hemodynamic shear stress via ROS modulates PCSK9 expression in human vascular endothelial and smooth muscle cells and along the mouse aorta. Antioxid Redox Signal. 2015, 22:760-771. 
  11. Ding Z, Liu S, Wang X, Deng X, Fan Y, Shahanawaz J, Shmookler Reis R, Varughese KI, Sawamura T, Mehta JL. Cross-talk between LOX-1 and PCSK9 in vascular tissues. Cardiovasc Res. 2015, 107:556-67.
  12. Ding Z, Liu S, Wang X, Dai Y, Khaidakov M, Deng X, Fan Y, Xiang David, Mehta JL. LOX-1, mtDNA damage and NLRP3 inflammasome activation in macrophages: implications in atherogenesis. Cardiovasc Res. 2014, 103:619-28. 
UAMS College of Medicine LogoUAMS College of MedicineUniversity of Arkansas for Medical Sciences
Mailing Address: 4301 West Markham Street, Little Rock, AR 72205
Phone: (501) 686-7000
  • Facebook
  • Twitter
  • Instagram
  • YouTube
  • LinkedIn
  • Pinterest
  • Disclaimer
  • Terms of Use
  • Privacy Statement

© 2023 University of Arkansas for Medical Sciences